# Peptides for Hair Growth: Evidence, Grades & Safety

> A clinical, evidence-first ranking of the peptides marketed for hair regrowth — zinc-thymulin, copper peptides, biotinoyl tripeptide-1 (Procapil) and PTD-DBM — graded honestly, with human versus preclinical evidence kept strictly separate.

*Published 2026-07-01 · Updated 2026-07-01 · By Elena Soto, PharmD*

The short answer
Hair-growth peptides are a field where the marketing has badly outrun the evidence. **Not one peptide reaches Grade A** — a large, independent, replicated human RCT — for hair regrowth. **Zinc-thymulin** tops out at a lower-bound Grade B on a single open-label pilot; **copper peptides**, **biotinoyl tripeptide-1 (Procapil)** and **PTD-DBM** are all Grade C. The only FDA-approved AGA drugs remain topical minoxidil and oral finasteride.[6](https://peptidevox.com/#r6)[12](https://peptidevox.com/#r12)

This article is informational and editorial content only — *not medical advice, not a prescription or protocol, and not a sourcing or buying guide*. None of the peptides discussed here is an FDA-approved drug for hair loss; the only FDA-approved pharmacologic treatments for androgenetic alopecia (AGA) remain topical minoxidil and oral finasteride.[12](https://peptidevox.com/#r12) Topical 'hair peptides' are sold as cosmetic ingredients or compounded/'research-chemical' preparations; injectable versions are unapproved and largely unstudied for hair. Doses and concentrations are reported strictly as they appear in the published literature, for completeness — never as a recommendation. Consult a board-certified dermatologist before acting on anything here, and patch-test any new topical.

## What actually drives hair loss, and how might peptides help?

Androgenetic alopecia is driven by dihydrotestosterone (DHT)-induced follicular miniaturization: in genetically susceptible follicles, DHT progressively shortens the anagen (growth) phase, shrinks the follicle, and converts terminal hairs to wispy vellus hairs.[12](https://peptidevox.com/#r12) From a root-cause, functional standpoint the appeal of peptides is that — unlike a pure vasodilator (minoxidil) or a systemic hormonal blockade (finasteride) — they aim to restore the follicle's own growth signaling. The proposed mechanisms, in descending order of how well they are supported, are Wnt/β-catenin reactivation (PTD-DBM displacing the CXXC5 brake), copper delivery with dermal-papilla support (raising VEGF, lowering TGF-β1), anagen prolongation via thymic peptides (zinc-thymulin), and matrikine 'anchoring' plus anagen support (biotinoyl tripeptide-1).[2](https://peptidevox.com/#r2)[1](https://peptidevox.com/#r1)[5](https://peptidevox.com/#r5)

The recurring caveat across all four is blunt: a culture-dish or mouse mechanism is a reason to hypothesize benefit, not proof of it in human scalps — and topical penetration to the dermal papilla is the rate-limiting step. That single structural truth, that **delivery is the bottleneck**, explains why the larger human numbers in the literature come from delivery-enhanced approaches (microneedling, micro-infusion, nanocarriers) and why those numbers cannot be credited to the peptide alone.[10](https://peptidevox.com/#r10)

## How do the peptides sort by evidence?

Within that sober frame the candidates sort cleanly. The table below ranks them by the directness of human evidence, keeping human, ex-vivo, animal and combination data strictly separate — the discipline this whole field usually lacks.

  Hair-growth peptides ranked by directness of human evidence (topical, for AGA)

    PeptideBest evidenceStandalone human efficacy data?Grade

    Zinc-Thymulin1 open-label pilot (n=18) + human follicle organ cultureYes — small, open-label, unblinded, single-investigatorB (lower bound)
    Copper peptides (GHK-Cu / AHK-Cu)Ex-vivo human follicle elongation + mechanism; confounded combo signalNo standalone RCT; only multi-drug combinationsC
    Biotinoyl Tripeptide-1 (Procapil)In-vitro + manufacturer/open-label combination human studiesCombination only — peptide effect not isolatedC
    PTD-DBMMouse regrowth + neogenesis; human balding scalp shows ↑CXXC5None (animal/mechanistic only)C
    Minoxidil & finasteride (not peptides)Large, replicated human RCTsYes — the FDA-approved benchmarkA

**Zinc-thymulin** leads narrowly because it is the only candidate with a dedicated human topical efficacy study of the peptide itself — Vickers et al. 2017, a single-investigator pilot in 18 AGA subjects, backed by human hair-follicle organ-culture work in which thymulin prolonged anagen versus vehicle.[6](https://peptidevox.com/#r6)[5](https://peptidevox.com/#r5) An honest wrinkle: in that organ culture, thymulin actually reduced hair-shaft elongation even while extending the growth phase, so the net human effect is not as clean as marketing implies.[5](https://peptidevox.com/#r5)

**Copper peptides** have the best tissue-level evidence — Pyo et al. cultured 240 isolated human scalp follicles and showed AHK-Cu at very low molarity stimulated follicle elongation and dermal-papilla-cell proliferation while suppressing apoptosis, with a coherent VEGF-up, TGF-β1-down mechanism.[1](https://peptidevox.com/#r1) Critically, the response is biphasic: growth was inhibited at higher concentrations, so more is not better. There is no standalone human RCT; the only in-vivo human signal comes from a two-patient micro-infusion report that also used minoxidil and dutasteride, so the peptide's solo effect cannot be isolated.[10](https://peptidevox.com/#r10) **Biotinoyl tripeptide-1 (Procapil)** is only ever tested inside multi-active formulas — the 2025 open-label trial in 48 patients and the earlier six-month study in 56 both blended it with oleanolic acid and apigenin — so its individual contribution is unproven.[7](https://peptidevox.com/#r7)[8](https://peptidevox.com/#r8) **PTD-DBM** has the most elegant mechanism (a Wnt/β-catenin activator that blocks CXXC5) but zero human efficacy data — mouse only, single-lab — even though CXXC5 is verifiably upregulated in human balding scalps.[2](https://peptidevox.com/#r2)[4](https://peptidevox.com/#r4)

## What does the evidence NOT support?

Several popular claims fail on the record. 'Peptides regrow hair as well as or better than minoxidil/finasteride' is unsupported: no peptide has a large independent human RCT, the 'outperformed minoxidil' figures for PTD-DBM come from mice, and for copper and biotinoyl peptides from in-vitro assays.[2](https://peptidevox.com/#r2)[9](https://peptidevox.com/#r9) 'PTD-DBM is a proven human hair treatment' is false — there is no human efficacy study at all.[2](https://peptidevox.com/#r2) 'Higher copper-peptide concentration equals more regrowth' inverts the data: growth was inhibited at higher concentrations in the biphasic dose-response.[1](https://peptidevox.com/#r1) And 'injectable hair peptides are a legitimate medical treatment' is unsupported — none has FDA approval or a controlled human efficacy trial for hair, and compounded or research-chemical preparations are unapproved with unverified purity and sterility.[14](https://peptidevox.com/#r14)

## What are the safety, contraindications and legal facts in 2026?

The critical distinction is topical versus injectable. Copper peptides and biotinoyl tripeptide-1 are sold as topical cosmetic ingredients with reasonable tolerability records; zinc-thymulin is typically a compounded prescription topical; PTD-DBM is an unapproved research chemical. Injectable or intradermal versions sold 'for research' carry the real risks of unregulated products — unknown purity and sterility, injection-site infection — and have no controlled human efficacy data for hair.[14](https://peptidevox.com/#r14) No peptide is FDA-approved for hair loss; the only approved AGA drugs are minoxidil and finasteride, with the HairMax LaserComb device-cleared.[12](https://peptidevox.com/#r12)[13](https://peptidevox.com/#r13)

Two contraindications matter most. **Wilson's disease and other copper-overload disorders are an absolute contraindication to copper peptides** (GHK-Cu, AHK-Cu).[11](https://peptidevox.com/#r11) Beyond that, patch-test any new topical for contact sensitivity, and treat pregnancy and lactation as precautionary given the absence of dedicated human safety data. On anti-doping, none of these hair peptides is named on the WADA Prohibited List and ordinary topical cosmetic use is not a doping concern; the only theoretical exposure is the S0 'non-approved substances' catch-all for an athlete using an injectable research-chemical version. Readers can confirm current status directly at the [WADA 2026 Prohibited List](https://www.wada-ama.org/en/prohibited-list).[15](https://peptidevox.com/#r15)

**Bottom line.** From a functional, root-cause standpoint peptides are a plausible adjunct aimed at restoring the follicle's own growth signaling — but the evidence-backed foundation for AGA remains the unglamorous core: address the DHT driver and follicle blood supply with the proven agents, correct nutritional contributors (iron/ferritin, vitamin D, and zinc — directly relevant since thymulin is zinc-dependent), and rule out thyroid and other systemic drivers.[13](https://peptidevox.com/#r13) Peptides are layered in as a hopeful complement, not a substitute for the basics, and no efficacy claim here should outrun the grade attached to it.

---
Source: https://peptidevox.com/skin-hair-aesthetic/peptides-for-hair-growth
Index: https://peptidevox.com/llms.txt · Full text: https://peptidevox.com/llms-full.txt